Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Co-diagnostics Inc. buy Biotechhunter

Co-diagnostics Inc.
Start price
€12.40
29.04.20 / 50%
Target price
-
04.05.20
Performance (%)
-1.61%
End price
€12.20
04.05.20
Summary
This prediction ended on 04.05.20 with a price of €12.20. With a performance of -1.61%, the BUY prediction for Co-diagnostics Inc. by Biotechhunter closed slightly in the red. Biotechhunter has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Co-diagnostics Inc. - - - -
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

According to Biotechhunter what are the pros and cons of Co-diagnostics Inc. for the foreseeable future?

Pros
Cons
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
very negative Cash Flow expected
Junk rating
Very little Investments for future growth
High risks in the balance sheet
High risks for its business
Nicheplayer
Outdated or very high risk business model

Comments by Biotechhunter for this prediction

In the thread Co-diagnostics Inc. diskutieren

Buy Co-diagnostics Inc.

Biotechhunter 
0
Report Share
29.04.20 Buy -1.61%
In the thread Trading Co-diagnostics Inc.
Prediction Buy
Perf. (%) -1.61%
Target price
Change
Ends at 04.05.20

Buy beendet

Biotechhunter 
0
Report Share
04.05.20

Stopped prediction by Biotechhunter for Co-diagnostics Inc.

sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€7.10
05.09.20
-
04.11.21
-12.39%
15.07.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
05.09.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€7.00
04.09.20
-
05.09.20
1.43%
05.09.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
04.09.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€7.75
04.09.20
-
04.09.20
-9.68%
04.09.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
04.09.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€7.75
03.09.20
-
04.09.20
0.00%
04.09.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
03.09.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€8.20
02.09.20
-
03.09.20
-5.49%
03.09.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
02.09.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€8.85
02.09.20
-
02.09.20
-7.34%
02.09.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
02.09.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€8.85
01.09.20
-
02.09.20
0.00%
02.09.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
01.09.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€9.10
31.08.20
-
01.09.20
-2.75%
01.09.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
31.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€9.15
28.08.20
-
31.08.20
-0.55%
31.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
28.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€9.25
28.08.20
-
28.08.20
-1.08%
28.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
28.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€9.65
27.08.20
-
28.08.20
-4.15%
28.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
27.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€11.90
20.08.20
-
27.08.20
-18.91%
27.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
20.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€12.30
19.08.20
-
20.08.20
-3.25%
20.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
19.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€12.90
18.08.20
-
19.08.20
-4.65%
19.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
18.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€13.30
17.08.20
-
18.08.20
-3.01%
18.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
17.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€14.00
17.08.20
-
17.08.20
-5.00%
17.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
17.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€14.70
17.08.20
-
17.08.20
-4.76%
17.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
17.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€14.80
13.08.20
-
17.08.20
-0.68%
17.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
13.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€18.20
13.08.20
-
13.08.20
-18.68%
13.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
13.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€18.40
13.08.20
-
13.08.20
-1.09%
13.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
13.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€17.10
12.08.20
-
13.08.20
7.60%
13.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
12.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€20.60
11.08.20
-
12.08.20
-16.99%
12.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
11.08.20 50%
sell
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€20.80
01.08.20
-
11.08.20
-0.96%
11.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
01.08.20 50%
buy
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€20.20
31.07.20
-
01.08.20
2.97%
01.08.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
31.07.20 50%
buy
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€19.70
24.07.20
-
31.07.20
2.54%
31.07.20

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Biotechhunter 
24.07.20 50%